T
Todd R. Golub
Researcher at Harvard University
Publications - 454
Citations - 234100
Todd R. Golub is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Gene expression profiling. The author has an hindex of 164, co-authored 422 publications receiving 201457 citations. Previous affiliations of Todd R. Golub include Rush University Medical Center & Boston Children's Hospital.
Papers
More filters
Patent
Across platform and multiple dataset molecular classification
TL;DR: In this paper, a large-scale Bayes classification framework for across platform and multiple dataset classification is proposed. In one embodiment, the systems combine a Large Bayes classifier with a definition of combined relative features to represent the original values.
Journal ArticleDOI
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer
Kevin Shee,Amanda Jiang,Frederick S. Varn,Stephanie Liu,Nicole A. Traphagen,Philip Owens,Cynthia X. Ma,Jeremy Hoog,Chao Cheng,Todd R. Golub,Ravid Straussman,Todd W. Miller +11 more
TL;DR: A transcriptomic signature of BMP4 signaling was predictive of an improved biologic response to the CDK4/6i palbociclib, in combination with an aromatase inhibitor in primary tumors.
Journal ArticleDOI
Identification of prostate cancer modifier pathways using parental strain expression mapping
Qing Xu,Pradip K. Majumder,Kenneth N. Ross,Yeonju Shim,Todd R. Golub,Massimo Loda,William R. Sellers +6 more
TL;DR: In multiple human prostate expression data set, it was found that enrichment of glycolysis pathways in normal tissues was associated with decreased rates of cancer recurrence after prostatectomy, suggesting that parental strain expression mapping can directly identify germ-line modifier pathways of relevance to human disease.
Journal ArticleDOI
Identification of Driver and Passenger Mutations of FLT3 by High-Throughput DNA Sequence Analysis and Functional Assessment of Candidate Alleles.
Stefan Fröhling,Claudia Scholl,Ross L. Levine,Marc M. Loriaux,Titus J. Boggon,Olivier Bernard,Roland Berger,Hartmut Döhner,Konstanze Döhner,Benjamin L. Ebert,Sewit Teckie,Todd R. Golub,Marcus M Schittenhelm,Benjamin H. Lee,James D. Griffin,Richard Stone,Michael Heinrich,Michael W. Deininger,Brian J. Druker,D. Gary Gilliland +19 more
TL;DR: The concept that acquired mutations in cancer may not contribute to malignant transformation is supported and the importance of functional validation of candidate alleles discovered using high-throughput genomic screens is underscored to distinguish between ‘driver’ mutations underlying cancer development, and biologically neutral ‘passenger’ alterations.
Journal ArticleDOI
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma
Eshini Panditharatna,Joana G Marques,Tingjian Wang,Maria Trissal,Ilon Liu,Li Jiang,Alexander M. Beck,Andrew K. Groves,Neekesh V. Dharia,Deyao Li,Samantha E Hoffman,Guillaume Kugener,McKenzie Shaw,Hafsa M Mire,Olivia A Hack,Joshua M. Dempster,Caleb A. Lareau,Lingling Dai,Logan H. Sigua,Michael Quezada,Ann Catherine J. Stanton,Meghan R. Wyatt,Zohra Kalani,Amy Goodale,Francisca Vazquez,Federica Piccioni,John G. Doench,David E. Root,Jamie N. Anastas,Kristen L Jones,Amy Saur Conway,Sylwia A. Stopka,Michael S. Regan,Yung-Yi Liang,Hyuk-Soo Seo,Kijun Song,Puspalata Bashyal,William P. Jerome,Nathan Mathewson,Sirano Dhe-Paganon,Mario L. Suvà,Angel M. Carcaboso,Cinzia Lavarino,Jaume Mora,Quang-Dé Nguyen,Keith L. Ligon,Sameer Agnihotri,Nathalie Y. R. Agar,Kimberly Stegmaier,Charles D. Stiles,Michelle Monje,Todd R. Golub,Jun Qi,Mariella G. Filbin +53 more
TL;DR: It is demonstrated that therapeutic inhibition of BAF complex has translational potential for children with H3K27M-gliomas, where genetic perturbation of the BAF catalytic subunit SMARCA4 (BRG1) opposes proliferation, promotes progression of differentiation along the astrocytic lineage, and improves overall survival of patient-derived xenograft models.